Clinical Trials in Denver

Showing 7961-7980 of 18,161 trials

A Study of t:Slim X2 With Control-IQ Technology

NCT03844789

The purpose of this study is to learn whether an investigational automated insulin delivery system ("study system") for children with type 1 diabetes can safely improve blood glucose (sometimes called blood sugar) control. The system uses continuous glucose monitoring (CGM), an insulin pump, and a software algorithm to automatically give insulin and control blood glucose. This is called a "closed-loop control" system.

Type 1 Diabetes Mellitus

University of Virginia101 participantsStarted Jun 2019

Stanford, California, United States • Aurora, Colorado, United States • New Haven, Connecticut, United States +1 more locations

COMPLETEDNA8.4 miles

Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease

NCT04534985

The proposed research will determine the feasibility of a time restricted feeding intervention,a fasting regimen that restricts eating to a feeding window (8 hrs/day) for 1 year in adults with autosomal dominant polycystic kidney disease (ADPKD) who are overweight or obese. The study will provide valuable information on the intervention in terms of safety, adherence, acceptability, and tolerability. Last, this pilot trial will provide initial insight into biological changes including abdominal adiposity, changes in kidney growth and function, and markers of biological pathways related to the intervention.

Polycystic Kidney, Autosomal Dominant

University of Colorado, Denver29 participantsStarted Feb 2021

Aurora, Colorado, United States

A Study of t:Slim X2 With Control-IQ Technology

Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease

Find Trials by Condition in Denver

Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment

Adaptive Responses to Overfeeding and Weight

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Biomarker Cost-Benefit Analysis of EFNEP

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi

N99-02: Melphalan and Buthionine Sulfoximine

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling

Ganaxolone Treatment in Children With Fragile X Syndrome

PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.

A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)